drugset / Trial / NCT03994874

Peritoneal Ultrafiltration in Cardio Renal Syndrome.

NCT03994874 ↗

Phase 1/2 Recruiting 84 enrolled Iperboreal Pharma Srl
RandomizedParallel-groupSingle-blindTreatment

Summary

Randomized, controlled, unblinded, adaptive design clinical trial to evaluate the safety and efficacy of PolyCore (Polydextrin, L-Carnitine, D-xylitol) peritoneal ultrafiltration (PUF) in patients with heart failure and reduced ejection fraction (HFrEF).

Timeline

Start
2025-04-16
Primary completion
2026-12
Completion
2027-06

Drugs

EvaluationDrugModalityDoseRoute
Subject PolyCore Unknown 2000 ml Other